This is not the most recent version of the article. View current version (20 JUL 2016)

Intervention Review

You have free access to this content

Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

  1. Karen A Robinson1,*,
  2. Olaide A Odelola2,
  3. Ian J Saldanha3

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 22 MAY 2014

Assessed as up-to-date: 12 MAY 2014

DOI: 10.1002/14651858.CD007743.pub5


How to Cite

Robinson KA, Odelola OA, Saldanha IJ. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD007743. DOI: 10.1002/14651858.CD007743.pub5.

Author Information

  1. 1

    Johns Hopkins University, Department of Medicine, Baltimore, MD, USA

  2. 2

    Albert Einstein Medical Center, Department of Internal Medicine, Philedelphia, PA, USA

  3. 3

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, MD, USA

*Karen A Robinson, Department of Medicine, Johns Hopkins University, 1830 E. Monument St., Suite 8068, Baltimore, MD, 21287, USA. krobin@jhmi.edu.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 22 MAY 2014

SEARCH

This is not the most recent version of the article. View current version (20 JUL 2016)

  1. You have free access to this content

    Current Version

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola and Ian J Saldanha

    Version of Record online: 20 JUL 2016 | DOI: 10.1002/14651858.CD007743.pub6

Previous versions of this article and their online publication dates

  1. You have free access to this content

    Version 5

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola and Ian J Saldanha

    Version of Record online: 22 MAY 2014 | DOI: 10.1002/14651858.CD007743.pub5

  2. You have free access to this content

    Version 4

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola, Ian J Saldanha and Naomi A Mckoy

    Version of Record online: 5 JUN 2013 | DOI: 10.1002/14651858.CD007743.pub4

  3. Version 3

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A Robinson, Olaide A Odelola, Ian J Saldanha and Naomi A Mckoy

    Version of Record online: 15 FEB 2012 | DOI: 10.1002/14651858.CD007743.pub3

  4. Version 2

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A. Robinson, Olaide A Odelola, Ian Saldanha and Naomi Mckoy

    Version of Record online: 17 FEB 2010 | DOI: 10.1002/14651858.CD007743.pub2

  5. Version 1

    Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis

    Karen A. Robinson, Olaide A Odelola, Ian Saldanha and Naomi Mckoy

    Version of Record online: 15 APR 2009 | DOI: 10.1002/14651858.CD007743